NSW Health's Safety Alert Broadcast System (SABS) has been adapted from the UK's National Health Service Safety Alert Broadcast System. Its aim is to provide a systematic approach to the distribution and management of patient safety information to NSW health services. Each alert specifies action to be taken by health services, the timeframe in which such action must occur, and specific responsibility for the actions.

The Safety Alert Broadcast System Policy Directive PD2013_009 describes how SABS works. Basically, there are three types of notification:

Safety Alert (Red), requiring immediate attention and action.

Safety Notice (Amber), requiring risk assessment at the local level.

Safety Information (Green), ensuring that lessons learned from state-wide, national and international sources are shared actively across the NSW health system.

The SABS register

NumberTypeIssues coveredDate of issue
Safety Information Green
Electronic Fetal Monitoring (EFM) during water immersion
​30 November 2021
Safety Information Green
Recirculating air filtration device use in NSW hospitals
​26 November 2021
​​SN:022/21 Safety Notice (Amber) Preparation of Pfizer COVID-19 vaccines​17 September 2021
​SN:021/21Safety Notice (Amber)Safety risks due to new labelling on the outer carton packaging of intravenous potassium chloride ampoules ​10 September 2021
​SN:020/21Safety Notice (Amber) Remdesivir 100mg injection –disruption to supply​9 September 2021
Safety Alert Red
Urgent stock preservation of tocilizumab injections for COVID-19 patients required
​31 August 2021
Safety Notice (Amber)
Flow sensors used in selected GE healthcare / datex-ohmeda anaesthesia machines
30 August 2021
​SI:004/21Safety Information Green Povidone-Iodine Solution Use in NSW Hospitals​19 August 2021
Safety Notice (Amber) Myocarditis and pericarditis after mRNA COVID-19 vaccines​18 August 2021
​SN:017/21Safety Notice (Amber) Illicit cocaine containing high levels of lidocaine (lignocaine)​13 August 2021
​SA:001/21Safety Alert RedCritical disruption to the supply of tocilizumab ​9 August 2021
Safety Notice (Amber)
​Identification and monitoring of Post-Injection Syndrome Olanzapine Pamoate Long Acting Injection (updated)
​9 August 2021
Safety Information Green Safe use of medications with multiple concentrations in Electronic Medication Management (EMM) systems​9 July 2021
​SN:015/21Safety Notice (Amber)Philips Sound Abatement Foam on selected sleep and respiratory devices – Product Defect Correction ​5 July 2021
​SN:014/21Safety Notice (Amber)25C-NBOMe toxicity in patients who used powder thought to be MDMA​2 July 2021
​SI:06/21 Safety Information Green Patient identity checks before administration of blood products​21 June 2021
​SN:012/21 Safety Notice (Amber) ​Enoxaparin 20 mg and 40 mg syringes: Disruption to supply​1 June 2021
​SI:05/21 Safety Information Green Reporting Adverse Events Following Immunisation​23 May 2021
​SI:003/21 Safety Information Green Paediatric stationary oxygen concentrator set-up - Absence of low flow alarm for flow rates less than 2 litres per minute​20 May 2021
​SN:010/21 Safety Notice (Amber)Requirements for post-transplant blood-borne virus surveillance of recipients of organs from increased-risk donors
​18 May 2021
Safety Notice (Amber)Illicit cocaine containing strong opioids
​14 May 2021
Safety Notice (Amber)Medtronic Covidien DAR™ airway products – Deviation in sterilisation processing​29 April 2021
Safety Notice (Amber)HYDROmorphone (Dilaudid®) Oral Liquid 1 mg/mL – Discontinued​17 March 2021
SN:003/21 Safety Notice (Amber) Breast implant associated-anaplastic large cell lymphoma (BIA-ALCL) 1 March 2021
SN:002/21 Safety Notice (Amber) Variability in oxygen delivery with bag valve masks
15 February 2021
SI:001/21 Safety Information Green Minimising the risks of serious harm while switching antipsychotics20 January 2021
Safety Notice (Amber) Discontinuation of nifedipine immediate release products (update)18 January 2021
SN:011/20 Safety Notice (Amber) Heroin and cocaine containing fentanyl and acetylfentanyl26 November 2020
SN:009/20 Safety Notice (Amber) Acetylfentanyl and fentanyl in non-opioid illicit drugs
16 October 2020
SI:005/20 Safety Information Green Safe use of disposable (single patient use) slings24 September 2020
SN:008/20 Safety Notice (Amber) Illicit supply of counterfeit alprazolam (Updated)9 September 2020
SN:004/20 Safety Notice (Amber) Lantus discontinuation and introduction of new insulin glargine products11 June 2020
SI:003/20 Safety Information Green The risk of toxicity from topical anaesthetic products22 May 2020
SN:002/20 Safety Notice (Amber) Management of medication for patients with Parkinson disease
(Supercedes SN:013/11)
11 March 2020
SN:001/20 Safety Notice (Amber) Safe provision of sedating medicines on discharge from NSW Health facilities18 February 2020
SA:001/20 Safety Alert Red LIFEPAK® 15 Monitor/Defibrillator defect correction - 202014 January 2020
SI:001/20 Safety Information Green Use of linen in radiological procedures potential artefact13 January 2020
SN:014/19 Safety Notice (Amber) Ranitidine – Product Recall4 October 2019
SN:013/19 Safety Notice (Amber) Incompatibility between oxygen cylinders with inbuilt regulators with Air/Oxygen Blenders26 September 2019
SN:012/19 Safety Notice Amber Link adrenaline (epinephrine) 1 in 10,000 prefilled syringe - device failure23 August 2019
SN:011/19 Safety Notice (Amber) Benzylpenicillin injection – disruption to supply14 August 2019
SN:010/19 Safety Notice Amber Heparin sodium injection 5000 units/0.2mL - disruption to supply5 August 2019
SN:007/19 Safety Notice (Amber) High Concentration Insulin Products (Updated)
(Supersedes SN:009/17)
24 June 2019
SN:004/19 Safety Notice Amber JJM Intraluminal Proximate Circular Stapler (ILS)4 April 2019
SN:021/18 Safety Notice Amber Discontinuation of nifedipine (twice daily products) and patient safety risks with alternative20 December 2018
SN:020/18 Safety Notice Amber Salem Sump Nasogastric Tube Shortage14 December 2018
SN:019/18 Safety Notice Amber Oxygen Cylinders with Integrated Valve Regulator29 November 2018
SN:018/18 Safety Notice Amber Newborn Self-Inflating Bag (SIB) resuscitators27 November 2018
SN:017/18 Safety Notice Amber Printing the correct ECG for patients
Correction to Para 2: QLD Health
27 November 2018
SN:015/18 Safety Notice Amber Parietex composite parastomal mesh hazard alert and recall9 November 2018
SI:003/18 Safety Information Green Candida auris infection considerations for the transfer or repatriation of an overseas patient to a NSW hospital7 September 2018
SN:012/18 Safety Notice Amber Rupture of membranes testing in maternity settings20 August 2018
SN:009/18 Safety Notice Amber Intragastric Balloon Systems6 August 2018
SN:008/18 Safety Notice Amber Return of Patients’ Own Medications25 July 2018
SI:001/18 Safety Information Green ABO Compatibility for Blood Products in an Emergency19 June 2018
SN:005/18 Safety Notice Amber Peri-operative risk of SGLT2 inhibitor–associated ketoacidosis15 March 2018
SN:003/18 Safety Notice Amber Complications Associated with Inferior Vena Cava Filters19 February 2018
SA:001/18 Safety Alert Red Vaccine storage and cold chain management9 February 2018
SN:015/17 Safety Notice Amber Transvaginal mesh implants for Pelvic Organ (Vaginal) Prolapse
(Supersedes SN:010/17)
20 December 2017
SN:011/17 Safety Notice Amber Disposable Ventilator Catheter Mounts Failure29 September 2017
SI:002/17 Safety Information Green Gadolinium-based contrast agents for MRI scans15 August 2017
SA:003/17 Safety Alert Red Infection from contaminated ultrasound gel 12 May 2017
SN:004/17 Safety Notice Amber Infection post cardiopulmonary bypass associated with heater-cooler devices
(Supersedes SN:007/16)
3 March 2017
SI:001/17 Safety Information Green Choking Risk in Mental Health Consumers 6 February 2017
SN:001/17 Safety Notice Amber Vaccine cold chain management in NSW Facilities 2 February 2017
SA:002/17 Safety Alert Red Insufflator Gas Connectors 12 January 2017
SA:001/17 Safety Alert Red HYDROmorphone: High-risk medicine
(Supersedes SA:004/11 and SN:011/10)
10 January 2017
SN:013/16 Safety Notice Amber Implantable cardiac defibrillator and cardiac resynchronization therapy defibrillator devices 18 November 2016
SN:011/16 Safety Notice Amber Povidone Iodine for pre-operative antisepsis – Disruption to supply 8 November 2016
(revised 21 November 2016)
SN:010/16 Safety Notice Amber Medical gas cylinders
(Supersedes Safety Notice 004/10 issued on 22 April 2010)
10 October 2016
SN:009/16 Safety Notice Amber Avoiding thrombophlebitis with intravenous amiodarone
(Supersedes Safety Notice 003/09 issued on 11 February 2009)

29 September 2016
(revised 10 February 2017)

SN:008/16 Safety Notice Amber Comfort impregnated cloth topical skin products: potential for bacterial contamination 20 September 2016
SI:002/16 Safety Information Green Switching between Extended Release (XR) vs Immediate Release (IR) Formulations25 August 2016
SN:004/16 Safety Notice Amber Assessment and management of risk of absconding from declared mental health inpatient units 22 June 2016
SN:003/16 Safety Notice Amber Use of Prone Restraint and Parenteral Medication in Healthcare Settings 14 July 2016
SN:001/16 Safety Notice Amber Changes to Medicine Ingredient Names - April 2016 to April 2020 9 May 2016
SI:001/16 Safety Information Green Increase in Cases of Invasive Meningococcal Disease 19 February 2016
SI:001/15 Safety Information Green E – Cigarettes, Oxygen Therapy, Burns and Fire Risk 20 January 2015
SN:004/14 Safety Notice Amber Removal of Central Venous Access Devices (CVAD) 12 August 2014
SA:002/14 Safety Alert Red Potential bacterial contamination of propofol
Update: Quarantine of Provive and Sandoz propofol all sizes and batches lifted
2 May 2014
15 July 2014
SI:001/14 Green Safety Information Correct Usage of Fume/Vapour Soaking Stations 24 January 2014
SN:001/14 Safety Notice Amber Use of Impregnated Chemical Disinfectant Wipe Systems for Reusable Medical Devices 24 January 2014
SI:003/13 Safety Information Green 25l-NBOMe Potent hallucinogenic substance in NSW 4 December 2013
(revised 19 December 2013)
SN:003/13 Safety Notice Amber Voluven and Volulyte (hydroxyethyl starch)5 September 2013
SI:002/12 Safety Information Green Measles Outbreak 31 August 2012
SI:001/12 Safety Information Green Antenatal magnesium sulphate infusion prior to preterm birth for neuroprotection of the foetus infant and child4 May 2012
SA:008/11 Safety Alert Red Pneumocystis jirovecii Pneumonia (PJP) in transplant patients19 December 2011
SN:015/11 Safety Notice Amber Bathing of Newborn Babies and Infection Prevention 22 November 2011
SN:017/10 Safety Notice Amber Group A Streptococcal Maternal Sepsis 24 December 2010
SN:010/10 Safety Notice Amber Correct identification of medication and solutions for epidural anaesthesia and analgesia 25 August 2010
SN:006/10 Safety Notice Amber Pathology Testing - Caesarean Section Operations 16 June 2010
SN:004/10 Safety Notice Amber Important Changes to Medical Gas Cylinders
(Superseded by Safety Notice 010/16 issued on 10 October 2016)
22 April 2010
SA:002/10 Safety Alert Red RECALL of Breathing Systems with Intersurgical #1986 Connector13 January 2010
SA:001/10 Safety Alert Red RECALL of Unomedical - Endotracheal Tubes8 January 2010
SN:022/09 Safety Notice Amber Safe use of Midazolam 18 December 2009
SA:006/09 Safety Alert Red Emergency/ Arrest Buttons 4 November 2009
SN:018/09 Safety Notice Amber Reducing Incidents Involving Tracheostomy Tube Care
To be read in conjunction with SN: 018/09
PD2006-098 - Tracheostomy - Unavoidable early (<72 hours) Tracheostomy Tube change
16 September 2009
SN:016/09 Safety Notice Amber Safe Instrumental Birth 28 July 2009
SN:014/09 Safety Notice Amber Retained or Broken Orthopaedic Surgical Equipment in Patients 9 July 2009
SA:003/09 Safety Alert Red Draeger Medical Babylog 8000 Plus Neonatal Ventilator26 June 2009
SA:002/09 Safety Alert Red Guidewire Alert16 June 2009
SI:003/09 Safety Information Green Varenicline (CHAMPIX)-Serious Psychiatric Side Effects29 May 2009
SN:011/09 Safety Notice Amber Allopurinol and Azathioprine 7 May 2009
SN:009/09 Safety Notice Amber Acute Coronary Syndrome 28 April 2009
SN:008/09 Safety Notice Amber Insertion of intraocular lens
Recommended intraocular lens insertion process
(To be read in conjunction with SN: 008/09)
31 March 2009
SN:006/09 Safety Notice Amber Wrong Route Errors with Oral Medication 25 March 2009
SA:001/09 Safety Alert Red PEEP Valve, Expiration Diverter Assembly 13 February 2009
SN:003/09 Safety Notice Amber Intravenous Amiodarone
(superseded by Safety Notice: 009/16)
11 February 2009
SI:001/09 Safety Information Green Drager Oxylog 2000 Transport Ventilator8 January 2009
SN:004/08 Safety Notice Amber Oxycodone (Revised)
Poster: Solid Oral Morphine and Oxycodone Products for Pain Relief
16 May 2008
SN:004/07 Safety Notice Amber Shower Curtain and Curtain Tracks in Mental Health Facilities 28 March 2007
SN:003/07 Safety Notice Amber Creutzfeldt - Jacob Disease (CJD) Transmission During High Risk Surgical Procedures
(“dorsal route ganglia” amended to read "dorsal root ganglia" - updated 20 March 07)
19 March 2007
(revised 20 March 2007)
SN:005/06 Safety Notice Amber Safe Use of Fentanyl Skin Patches
(Web address for Analgesic Skin Patches publication updated on 22 February 2007)
23 Octobter 2006
(revised 22 February 2007)
SN:003/06 Safety Notice Amber Peiron Stent fracture in renal arteries
October 2006
SI:001/06 Safety Information Green Alaris SE pumps recall, Filshie Clip System, peanut allergies, Bisphosphonates medications
(Web address for NSW Health peanut allergy publication updated on 23 March 2007)
8 September 2006
(revised 23 March 2007)

Current as at: Tuesday 30 November 2021